| Income Statement |
| Operating Expenses | 4.50M |
|
| Research and Development Expense | 578.00K |
| Selling, General and Administrative Expense | 3.93M |
| Operating Income | -4.50M |
| Net Income | -10.37M |
| Net Income Common Stock | -10.37M |
| Net Income Common Stock (USD) | -10.37M |
| Consolidated Income | -10.37M |
| Earnings per Basic Share | -4.13 |
| Earnings per Basic Share (USD) | -4.13 |
| Earnings per Diluted Share | -4.13 |
| Earning Before Interest & Taxes (EBIT) | -10.37M |
| Earning Before Interest & Taxes (USD) | -10.37M |
| Weighted Average Shares | 2.51M |
| Weighted Average Shares Diluted | 2.51M |
| Balance Sheet |
| Cash and Equivalents | 183.00K |
| Cash and Equivalents (USD) | 183.00K |
| Investments | 29.01M |
| Investments Current | 18.07M |
| Investments Non-Current | 10.94M |
| Current Assets | 19.02M |
| Total Assets | 30.59M |
| Current Liabilities | 21.54M |
| Total Liabilities | 21.71M |
| Accumulated Retained Earnings (Deficit) | -256.60M |
| Accumulated Other Comprehensive Income | 26.00K |
| Shareholders Equity | 9.59M |
| Shareholders Equity (USD) | 9.59M |
| Assets Non-Current | 11.57M |
| Liabilities Non-Current | 166.00K |
| Trade and Non-Trade Payables | 3.60M |